Treatment of UC With Novel Therapeutics

Abroad (travel likely)RecruitingPHASE2

Conditions

Ulcerative Colitis Mild · Ulcerative Colitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Brigham and Women's Hospital, Chestnut Hill, Massachusetts, United States
Contact: Study coordinator (Siani Ellis) · sellis13@bwh.harvard.edu · 617-396-7703
Contact: Study coordinator (Sophie Mitchell) · smitchell22@bwh.harvard.edu
Contact: Principal Investigator (Joshua Korzenik, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis

Ulcerative Colitis (UC) · Inflammatory Bowel Disease (IBD) · Colitis

Abroad (travel likely)Recruiting

Izmir, Turkey (Türkiye)

Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Abroad (travel likely)Recruiting

Cheras, Malaysia

Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE4

Garden Grove, United States · Indianapolis, United States

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis Chronic Mild · Ulcerative Colitis Chronic Moderate · Ulcerative Colitis Chronic

Abroad (travel likely)RecruitingPHASE1

Valencia, United States · Miami, United States